Table 9.
Organ/Findings (after exposure) | Grade | Dose (mg/m3) | |||
---|---|---|---|---|---|
| |||||
0 | 0.5 | 2.5 | 10 | ||
No. of animals examined | 8 | 8 | 8 | 8 | |
Normal appearance | 6 | 0 | 0 | 0 | |
Lung | |||||
Alveolar proteinosis | ± | 0 | 7 | 7 | 6 |
+ | 0 | 1 | 1 | 1 | |
++ | 0 | 0 | 0 | 1 | |
Hyperplasia/hypertrophy, alveolar type II cells | ± | 0 | 1 | 0 | 1 |
Aggregation, alveolar macrophages | ± | 0 | 2 | 0 | 1 |
+ | 0 | 3 | 0 | 0 | |
Infiltration, inflammatory cells, alveolar/perivascular | ± | 2 | 3 | 5 | 2 |
+ | 0 | 0 | 0 | 1 | |
++ | 0 | 0 | 0 | 1 | |
Lymph node, hilar | |||||
Aggregation, macrophages | ± | 0 | 1 | 0 | 1 |
+ | 0 | 0 | 0 | 1 | |
| |||||
Organ/Findings (after recovery) | Grade | Dose (mg/m3) | |||
| |||||
0 | 0.5 | 2.5 | 10 | ||
| |||||
No. of animals examined | 8 | 8 | 7 | 8 | |
Normal appearance | 5 | 1 | 0 | 0 | |
Lung | |||||
Alveolar proteinosis | ± | 0 | 6 | 5 | 0 |
+ | 0 | 0 | 1 | 6 | |
++ | 0 | 0 | 0 | 2 | |
+++ | 0 | 0 | 1 | 0 | |
Hyperplasia/hypertrophy, alveolar type II cells | ± | 0 | 0 | 0 | 1 |
+ | 0 | 0 | 0 | 1 | |
Aggregation, alveolar macrophages | ± | 0 | 6 | 3 | 1 |
+ | 0 | 0 | 1 | 1 | |
++ | 0 | 0 | 1 | 0 | |
Infiltration, inflammatory cells, alveolar/perivascular | ± | 3 | 1 | 2 | 2 |
+ | 0 | 0 | 1 | 1 | |
+++ | 0 | 0 | 0 | 1 | |
Lymph node, hilar | |||||
Aggregation, macrophages | ± | 0 | 0 | 1 | 0 |
+ | 0 | 0 | 1 | 0 | |
++ | 0 | 0 | 0 | 3 | |
+++ | 0 | 0 | 0 | 1 |
Grade: ±, minimal; +, mild; ++, moderate; and +++, marked.